So, visfatin had strongly been related to pro-inflammatory factors in severe obesity [97], a novel marker of hypertension in advanced age patients [98] and a predictor of inflammation and endothelial injury in several metabolic diseases [99]. Here, NAMPT is linked to obesity disorder.